Announcement on Abnormal Fluctuations in Stock Trading
Filed with SSE · · 2 pages · Chinese
Guizhou Yibai Pharmaceutical Co. Ltd. on 6ix
Earlier from Guizhou Yibai Pharmaceutical
- Announcement on Obtaining the Drug Registration Certificate for Azacitidine for Injection
- Earnings Preannouncement for 2025
- Indicative Announcement on Expected Loss in Performance for 2025
- Announcement on Changing Annual Audit Institution’s Signatory Certified Public Accountant
- Announcement on Pledge and Pledge Release of Some Shares Held by Controlling Shareholder
Later from Guizhou Yibai Pharmaceutical
- Announcement on Provision for Impairment of Related Assets in 2025
- Announcement on Attending 2026 Collective Reception Day for Investors of Listed Companies in Guizhou Jurisdiction and 2025 Annual Performance Briefing
- Announcement on Changing the Use of Shares Repurchased and Cancellation and Notice to Creditors
- Announcement on Resolutions of the 17th Meeting of the 8th Board of Directors
- Announcement on Election of Employee Representative Director
Follow Guizhou Yibai Pharmaceutical into a list and get an email when it puts out news.
Follow Guizhou Yibai Pharmaceutical